Notably, the high expression of glycolytic key enzymes such as PFKL and GAPFH, downstream of HIF1A, was identified as the driving force behind the increased activation of glycolytic metabolic pathways within tumour cells (Figure 5H, Figure S5B,C). The gene discussed is HIF1A; the disease is neoplasm.